ENThe word “chemotherapy” frightens more than it should, usually because people picture the treatment of twenty years ago. What matters most has changed since: what is prescribed, to whom, and instead of what.
This page is about chemotherapy for lung cancer in Germany: how hospitals decide whether it is needed, what is always established before the first cycle, how cycles run and how side effects are handled. All treatment options: lung cancer treatment in Germany.
What is established before the first cycle
Three things are established, the most important being the tumour type: non-small cell and small cell lung cancer are treated differently, and a pathologist confirms the type on the biopsy, tissue examined under a microscope. If the report is rare or unclear, German hospitals review the slides, which sometimes changes the whole plan.
Second: molecular testing for gene changes in tumour cells, and measurement of PD-L1, a protein that helps the tumour hide from immune defences. In some patients a fault with a matching targeted tablet turns up, and chemotherapy is then not started at all. A high PD-L1 level suggests immunotherapy may work better; see immunotherapy for lung cancer. In Germany these tests come before treatment is chosen, not after a failed course.
Third: the stage and general condition, assessed with CT, often PET-CT showing deposits anywhere in the body, blood tests including kidney and liver function, and checks of the heart and other conditions. An aggressive regimen is not given to someone in poor condition, as it can do harm.
When chemotherapy is prescribed
Chemotherapy is prescribed before surgery, after it or instead of it. Beforehand it aims to shrink the tumour and improve the chance of removing it whole; recently it is more often combined with an immune drug, and the tumour board, a meeting of specialists, decides. See surgery for lung cancer.
After surgery it is given when the pathology shows involved lymph nodes or other features that make recurrence more likely, to act on cells that no scan can show.
Without surgery it accompanies radiotherapy when the tumour cannot be removed but has not left the chest, and is the main treatment in advanced disease and small cell lung cancer. The aim differs: sometimes cure, sometimes holding the disease back and preserving how the person feels, and the doctor names it openly.
How a course is built
A course is built from cycles: a day or two of infusions, a pause to recover, then again. Usually two drugs are combined, with an immune drug added for some tumours; the oncologist names the regimen and number of cycles, which depend on the tumour type.
Most courses in Germany run in a day unit: the patient comes in the morning for the infusion and leaves. Admission is needed for a complex regimen’s first dose or for complications. This matters for the trip: pauses between cycles can be spent at home if the doctor allows flying.
Blood tests precede every cycle and a CT follows a set number of cycles; then the result is reviewed and the regimen continued, changed or stopped. The procedure as such: chemotherapy in Germany.
Side effects: what is done in advance
Preparation starts before the first infusion, by naming what is met most often: nausea, tiredness, falling blood counts, changes in taste, hair loss with some regimens and numbness in the fingers.
A German hospital does not wait for complaints: anti-sickness drugs come before the infusion, blood counts are checked on schedule, and a written sheet lists the signs that mean calling at once, fever first. Where needed, drugs supporting blood counts are given. The Cancer Information Service of the German Cancer Research Center covers drug treatment for lung cancer (in German).
Much depends on the patient: food and fluids, mouth care, manageable activity between cycles, and honesty about how they feel instead of enduring. Separately: do not change prescriptions or add supplements without telling the doctor.
Where it is treated and how to continue at home
Drug treatment for lung cancer is the work of oncology and pulmonology departments. One AlenMed partner is University Hospital Tübingen, where Prof. Lars Zender heads the clinic for medical oncology and pulmonology. His fields are medical oncology, personalised oncology, early-phase trials and molecular oncology, and he is a managing director of the National Center for Tumor Diseases in south-west Germany (NCT SüdWest).
For the patient this means treatment matched to the tumour’s molecular profile and access to early-phase trials of new drugs, which an ordinary department lacks. But inclusion in a trial is the hospital’s decision and cannot be promised.
To continue at home, the German hospital issues a written plan: which drugs, in what order, which tests before each cycle, what to do about complications. The doctor at home needs it translated. By agreement some cycles are given locally, with trips back only for review.
Frequently asked questions
Is chemotherapy always needed for lung cancer?
No. If the tumour has a fault with a matching targeted drug, treatment usually starts with tablets; with a high PD-L1 level it sometimes starts with immunotherapy alone. After an early-stage tumour is removed, not everyone needs chemotherapy: the pathology decides. So the decision waits for all test results.
How long does chemotherapy for lung cancer take?
It depends on the aim and the tumour type; the oncologist sets the timeline. Before or after surgery the number of cycles is limited and known in advance. In advanced disease the main cycles are often followed by maintenance treatment, continued while it holds the disease back and is tolerated.
Will I lose my hair with chemotherapy for lung cancer?
It depends mainly on the drugs: some regimens cause hair loss, others milder loss or none, and the oncologist can tell you in advance. Hair usually starts falling out gradually a few weeks into treatment and normally grows back within weeks or months after the course.
How AlenMed arranges the treatment
It starts with the documents to send: the histology report, better still slides or blocks, molecular results if available, CT and PET-CT discs, recent blood tests, discharge letters and the medication list. The department replies what is worth prescribing, how many days the first visit takes and whether admission is needed; then follow a written estimate, a visa invitation, back-to-back appointments and an interpreter. More on arranging treatment in Germany.
Plan for spare time after the first cycle, someone to travel with and an agreement with the doctor at home.
This material is for information only, not an offer; the treatment plan is decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
